As the knockdown of HDAC9 induces BRM in both non-Rhabdoid [25] as well as in Rhabdoid cancer cell lines, these data support the hypothesis that HDAC9 is central to the epigenetic suppression of BRM in human tumors. This evidence concerns the gene HDAC9 and rhabdoid tumor.